1 completed, 1 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Recruiting 1 |
Follow Atypical Hemolytic Uremic Syndrome: new trials by email Literature Review of Atypical Hemolytic Uremic Syndrome trials Research Report on Atypical Hemolytic Uremic Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS Ravulizumab - aHUS, Atypical Hemolytic Uremic Syndrome | Phase 4 | Recruiting | Alexion Pharmaceuticals, Inc. | 20 | 2025-12-19 | 2026-04-20 |
| Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS eculizumab - Atypical Hemolytic Uremic Syndrome | Phase 4 | Completed | Nantes University Hospital | 58 | 2015-11-01 | 2026-09-14 |
Anemia (2) · Anemia, Hemolytic (2) · Blood Platelet Disorders (2) · Cytopenia (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemolytic-Uremic Syndrome (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Thrombocytopenia (2) · Thrombotic Microangiopathies (2) · Uremia (2) · Urogenital Diseases (2)
eculizumab (1) · ravulizumab (1)
Alexion Pharmaceuticals, Inc. (1) · Nantes University Hospital (1)
France (1) · Japan (1)